Abbott Laboratories
ABT
#77
Rank
NZ$366.22 B
Marketcap
NZ$210.42
Share price
-0.33%
Change (1 day)
8.47%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2025 (TTM): NZ$14.10

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$13.93. In 2024 the company made an earnings per share (EPS) of NZ$13.37 an increase over its 2023 EPS that were of NZ$5.70.

EPS history for Abbott Laboratories from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$14.105.47%
2024NZ$13.37134.51%
2023NZ$5.70-23.23%
2022NZ$7.437.5%
2021NZ$6.9157.41%
2020NZ$4.3921.54%
2019NZ$3.6154.75%
2018NZ$2.33389.07%
2017NZ$0.48-71.01%
2016NZ$1.65-68.01%
2015NZ$5.1496.13%
2014NZ$2.62-8.64%
2013NZ$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.05 29.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.97-78.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$29.98 115.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.32-68.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.28-54.95%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Bristol-Myers Squibb
BMY
NZ$5.14-63.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$3.27-76.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.25-62.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$12.73-8.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$6.22-55.37%๐Ÿ‡ฌ๐Ÿ‡ง UK